Qualigen Therapeutics Invests in NanoSynex’s Growth
PremiumCompany AnnouncementsQualigen Therapeutics Invests in NanoSynex’s Growth
2M ago
Qualigen Therapeutics to participate in next funding round for NanoSynex
Premium
The Fly
Qualigen Therapeutics to participate in next funding round for NanoSynex
2M ago
Qualigen Therapeutics regains compliance with Nasdaq’s min bid price
Premium
The Fly
Qualigen Therapeutics regains compliance with Nasdaq’s min bid price
4M ago
Qualigen Therapeutics to implement 1-for-50 reverse stock split
PremiumThe FlyQualigen Therapeutics to implement 1-for-50 reverse stock split
5M ago
Qualigen Therapeutics files to sell 14M shares of common stock
Premium
The Fly
Qualigen Therapeutics files to sell 14M shares of common stock
5M ago
Qualigen Therapeutics Board Experiences Key Changes
Premium
Company Announcements
Qualigen Therapeutics Board Experiences Key Changes
6M ago
Qualigen Therapeutics prices 14.7M shares at 13c in public offering
PremiumThe FlyQualigen Therapeutics prices 14.7M shares at 13c in public offering
7M ago
3 Penny Stocks to Watch Now, 7/16/24
Premium
Market News
3 Penny Stocks to Watch Now, 7/16/24
9M ago
Qualigen Therapeutics Secures Loan and Adjusts Board Structure
Premium
Company Announcements
Qualigen Therapeutics Secures Loan and Adjusts Board Structure
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100